Concern about the stock market’s overvaluation is going mainstream. For years now, those who have worried about the equity market’s overvaluation have been voices in the wilderness. As the ...

Companies in the S&P 500 appear increasingly focused on tariff policies under President Donald Trump, a point of potential volatility for the U.S. stock market, according to a research note from ...

The Street-high price target of $306 suggests an upside potential of 28.7%. On the date of publication, Rashmi Kumari did not have (either directly or indirectly) positions in any of the ...

He has flown under the radar as far as The Masked Singer panel are concerned, but a 90s music legend is now favourite to be Wolf with a growing number of fans and bookies, all thanks to the voice ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associated with opioids. The drug, which works by ...

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Federal officials on ...

Vertex attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...